Differential expression of smooth muscle myosin, smooth muscle actin, H-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue

American Journal of Dermatopathology

Volumn 28, Issue 2, 2006, Pages 105-111

  Perez Montiel, Maria Delia ^a,b   Plaza, Jose Antonio ^a   Dominguez Malagon, Hugo ^b   Suster, Saul ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Calponin; Fibromatosis; h caldesmon; Myofibroblastic lesions; Myofibroblastic sarcoma; Nodular fasciitis; Smooth muscle actin; Smooth muscle myosin

Indexed keywords

CALDESMON; CALPONIN; HIGH MOLECULAR WEIGHT CALDESMON; MYOSIN; SMOOTH MUSCLE ACTIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; FASCIITIS; FEMALE; FIBROBLAST; FIBROMATOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; MALE; MUSCLE TUMOR; MYOFIBROBLAST; PRIORITY JOURNAL; PSEUDOSARCOMA; SKIN TUMOR; SOFT TISSUE SARCOMA; TUMOR DIAGNOSIS;

ACTINS; ADULT; AGED; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; CALMODULIN-BINDING PROTEINS; FASCIA; FASCIITIS; FEMALE; FIBROBLASTS; FIBROMA; HUMANS; LEIOMYOMA; LEIOMYOSARCOMA; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; MUSCLE PROTEINS; SARCOMA; SKIN NEOPLASMS; SMOOTH MUSCLE MYOSINS; SMOOTH MUSCLE TUMOR; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33747676146     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.dad.0000200009.02939.cc     Document Type: Article

References (24)

1. Takahashi K, Hiwada K, Kokubu T. Isolation and characterization of a 34,000-dalton calmodulin- and F-actin-binding protein from chicken gizzard smooth muscle. Biochem Biophys Res Commun. 1986;26:20-26.
2. Miettinen MM, Sarlomo-Rikala M, Kovatich AJ, et al. Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation. Mod Pathol. 1999;12:756-762.
3. Foschini MP, Scarpellini F, Gown AM, et al. Differential expression of myoepithelial markers in salivary, sweat and mammary glands. Int J Surg Pathol. 2000;8:29-37.
4. Laskin WB, Fetsch JF, Miettinen MM. The "neurothekoma": immunohistochemical analysis distinguishes the true nerve sheath myxoma from its mimics. Hum Pathol. 2000;31:1230-1241.
5. Loddenkemper C, Mechsner S, Foss HD, et al. Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma. Am J Surg Pathol. 2003;27:1458-1462.
6. Watanabe K, Kusakabe T, Hoshi N, et al. H-caldesmon in leiomyosarcomas and tumors with smooth muscle-cell like differentiation: its specific expression in smooth muscle cell tumor. Hum Pathol. 1999;30:392-396.
7. Ceballos KM, Nielsen GP, Selig MK, et al. Is anti h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study. Am J Clin Pahol. 2000;114:746-753.
8. Rush DS, Tan JY, Baergen RN, et al. H-caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Am J Surg Pathol. 2001;25:253-258.
9. Hisaoka M, Wei-Qi S, Jian W, et al. Specific but variable expression of H-caldesmon in leiomyosarcomas. An immunohistochemical reassessment of a novel myogenic marker. Appl Immunohistochem Mol Morphol. 2001;9:302-308.
10. D'Addario SF, Morgan M, Talley L, et al. H-Cladesmon as a specific marker of smooth muscle cell differentiation in some soft tissue tumors of the skin. J Cutan Pathol. 2002;29:426-429.
11. Sakamoto A, Oda Y, Yamamoto H, et al. Calponin and H-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma. Virchows Arch. 2002;440:404-409.
12. Kalof AN, Tam D, Beatty B, et al. Immunostaining patterns of myoepithelial cells in breast lesions: a comparison of CD10 and smooth muscle myosin heavy chain. J Clin Pathol. 2004;57:625-629.
13. Matsui K, Tatsuguchi A, Valencia J, et al. Extrapulmonary lymphangioleiomyomatosis (LMA): clinicopathologic features in 22 cases. Hum Pathol. 2000;31:1242-1248.
14. Bruecks AK, Trotter MJ. Expression of desmin and smooth muscle myosin heavy chain in dermatofibromas. Arch Pathol Lab Med. 2002;126:1179-1183.
15. Agoff SN, Grieco VS, Garcia R, et al. Immunohistochemical distinction of endometrial stroma sarcoma and cellular leiomyoma. Appl Immunohistochem Mol Morphol. 2001;9:164-169.
16. Suster S. Recent advances in the application of immunohistochemical markers for the diagnosis of soft tissue tumors. Semin Diagn Pathol. 2000;17:225-235.
17. Rangdaeng S, Troung LD. Comparative immunohistochemical staining for desmin and muscle-specific actin: a study of 576 cases. Am J Clin Pathol. 1991;96:32-45.
18. Magro G, Bisceglia M, Michal M. Expression of steroid hormone receptors, their regulated proteins, and bcl-2 protein in myofibroblastoma of the breast. Histopathology. 2000;36:515-521.
19. Weiss SW, Goldblum JR. Benign fibrous tissue tumors. In: Weiss SW, Goldblum JR, eds. Enzinger and Weiss's Soft Tissue Tumors. 4th ed. Mosby: St Louis; 2001:247-307.
20. Montgomery EA, Meis JM. Nodular fasciitis. Am J Surg Pathol. 1991;15:942-948.
21. Magro G, Gurrera A, Bisceglia M. H-caldesmon expression in myofibroblastoma of the breast: evidence supporting the distinction from leiomyoma. Histopathology. 2003;42:233-238.
22. Mentzel T, Dry S, Katenkamp D, et al. Low grade myofibroblastic sarcoma. Analysis of 18 cases in the spectrum of myofibroblastic tumors. Am J Surg Pathol. 1998;22:1228-1238.
23. Singer II. The fibronexus: a transmembrane association of fibronectin-containing fibres in hamster and human fibroblasts. Cell. 1979;16:675-685.
24. Eyden B. The fibronexus in reactive and tumoral myofibroblasts: further characterisation by electron microscopy. Histol Histopathol. 2001;16:57-70.